Furthermore, a deeper understanding of Artemisiae Annuae Herba drug metabolism, coupled with the use of albumin and other related carriers to slow down drug half-life and maintain blood drug concentrations, could provide a solution for long-term and stable anti-cancer needs, positioning it advantageously for clinical translation. The gene discussed is ALB; the disease is cancer.